To evaluate the effect of IL-6 administration on T/HS-induced liver inflammation, we measured MPO positive cells in the livers of rats subjected to T/HS with the most severe T/HS protocol (50% SBR) and randomly assigned to receive either PBS (SBR50) or IL-6 (10 μg/kg, SBR50/IL-6) at the beginning of resuscitation. This evidence concerns the gene MPO and Hepatitis.